Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer ...Middle East

HEIDELBERG, Germany , May 29, 2024 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced it has received clearance of its Investigational New Drug (IND) Application from the U.S. Food and Drug Administration (FDA) for...

Hence then, the article about full life technologies announces clearance from fda of ind application for 225ac fl 020 for the treatment of metastatic castration resistant prostate cancer was published today ( Thursday 30/05/2024 - 03:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer )

Also on site :

• commercetools Kicks Off NRF 2026 - including Updates on Stripe ACS, AI Hub, and Helping Enterprises Stay Discoverable and Shoppable in Agentic Commerce
• inDrive turns to ads and groceries to diversify revenue
• Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates